Hematology and Oncology

Differences in socioeconomic status contribute to survival disparities for Hispanic Black and White patients

Adults aged 18 to 64 years living in non-Medicaid expansion states twice as likely to be uninsured as those living in expansion states

For premenopausal women receiving ovarian suppression, risk for breast cancer recurrence reduced with aromatase inhibitor versus tamoxifen

Drug was to be used alongside chemotherapy for patients with metastatic non-small cell lung cancer

Overall survival longer with cemiplimab versus single-agent chemo for recurrent disease after first-line platinum-containing chemo

Rate of event-free survival higher with neoadjuvant pembrolizumab plus chemo versus chemo alone for early triple-negative breast cancer

Issues include increased burden of COVID-19 in patients with cancer, lessons from COVID-19 with potential to improve cancer care

Mortality rates 41 percent higher for breast cancer for Black women, despite similar or lower incidence rates compared with Whites

Median progression-free survival significantly prolonged with trametinib versus one of five standard-of-care treatment options

Recipient plasma neutralization titers were 6.2 percent of donor titers as early as 30 minutes after transfusion